How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like Vanda Release: Company To Announce Fourth Quarter And Full Year 2016 Financial Results On February 15, 2017 January 19, 2017 FDA Calls BioMarin's Hemophilia A Drug a Breakthrough October 25, 2017 St. Jude Medical Settles Lawsuit Over CRM Leads for $39 Million July 8, 2016
Vanda Release: Company To Announce Fourth Quarter And Full Year 2016 Financial Results On February 15, 2017 January 19, 2017
